Brian A. Johns

3.8k total citations
59 papers, 2.7k citations indexed

About

Brian A. Johns is a scholar working on Infectious Diseases, Virology and Organic Chemistry. According to data from OpenAlex, Brian A. Johns has authored 59 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Infectious Diseases, 24 papers in Virology and 21 papers in Organic Chemistry. Recurrent topics in Brian A. Johns's work include HIV/AIDS drug development and treatment (29 papers), HIV Research and Treatment (24 papers) and Biochemical and Molecular Research (11 papers). Brian A. Johns is often cited by papers focused on HIV/AIDS drug development and treatment (29 papers), HIV Research and Treatment (24 papers) and Biochemical and Molecular Research (11 papers). Brian A. Johns collaborates with scholars based in United States, Japan and Spain. Brian A. Johns's co-authors include Kristjan S. Gudmundsson, James A. Marshall, Carl R. Johnson, Scott H. Allen, Paulo Shiroma, Edward P. Garvey, Kelvin O. Lim, Paul Thuras, Mark Underwood and Tamio Fujiwara and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Brian A. Johns

58 papers receiving 2.6k citations

Peers

Countries citing papers authored by Brian A. Johns

Since Specialization

Citations

This map shows the geographic impact of Brian A. Johns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian A. Johns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian A. Johns more than expected).

Fields of papers citing papers by Brian A. Johns

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian A. Johns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian A. Johns. The network helps show where Brian A. Johns may publish in the future.

Co-authorship network of co-authors of Brian A. Johns

This figure shows the co-authorship network connecting the top 25 collaborators of Brian A. Johns. A scholar is included among the top collaborators of Brian A. Johns based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian A. Johns. Brian A. Johns is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Molecular design and evaluation of aza-polycyclic carbamoyl pyridones as HIV-1 integrase strand transfer inhibitors 2024 ·Bioorganic & Medicinal Chemistry Letters ·Toshiyuki Akiyama, Brian A. Johns, Yoshiyuki Taoda, Hiroshi Yoshida, Teruhiko Taishi, Takashi Kawasuji, Hitoshi Murai, Tomokazu Yoshinaga, Akihiko Sato, Takahiro Seki, (unknown), Shigeru Miki, (unknown), (unknown), Tamio Fujiwara	3
2	Parenteral platforms for tunable, long-acting administration of a highly hydrophobic antiretroviral drug 2024 ·Scientific Reports ·(unknown), Marc M. Baum, Manjula Gunawardana, John A. Moss, (unknown), (unknown), Rob Fanter, (unknown), (unknown), Leonard M. Azzarano, (unknown), Beat M. Jucker, Brian A. Johns, (unknown), (unknown)	0
3	Economic Impact of Treatment Adherence in Exocrine Pancreatic Insufficiency (EPI) Patients Treated with Pancreatic Enzyme Replacement Therapy (PERT) 2018 ·Value in Health ·N Khandelwal, (unknown), Brian A. Johns, (unknown), Jane Castelli‐Haley, (unknown)	4
4	Discovery of a novel and potent class of anti-HIV-1 maturation inhibitors with improved virology profile against gag polymorphisms 2017 ·Bioorganic & Medicinal Chemistry Letters ·Jun Tang, Stacey A. Jones, Jerry Jeffrey, Sónia Miranda, Cristin M. Galardi, David M. Irlbeck, Kevin Brown, Charlene McDanal, Brian A. Johns	19
5	Facial recognition of happiness among older adults with active and remitted major depression 2016 ·Psychiatry Research ·Paulo Shiroma, Paul Thuras, Brian A. Johns, Kelvin O. Lim	15
6	The design of 8-hydroxyquinoline tetracyclic lactams as HIV-1 integrase strand transfer inhibitors 2016 ·European Journal of Medicinal Chemistry ·(unknown), Brian A. Johns, (unknown), Kevin Brown, (unknown)	22
7	The Effect of Repeated Ketamine Infusion Over Facial Emotion Recognition in Treatment-Resistant Depression: A Preliminary Report 2015 ·Journal of Neuropsychiatry ·Paulo Shiroma, C. Sophia Albott, Brian A. Johns, Paul Thuras, Joseph Wels, Kelvin O. Lim	9
8	Inhibition of the Ribonuclease H Activity of HIV-1 Reverse Transcriptase by GSK5750 Correlates with Slow Enzyme-Inhibitor Dissociation 2014 ·Journal of Biological Chemistry ·Greg L. Beilhartz, (unknown), Brian A. Johns, Felix Deanda, Peter Gerondelis, Matthias Götte	25
9	Naphthyridinone (NTD) integrase inhibitors 4. Investigating N1 acetamide substituent effects with C3 amide groups 2014 ·Bioorganic & Medicinal Chemistry Letters ·Brian A. Johns, Takashi Kawasuji, Jason G. Weatherhead, Eric E. Boros, James B. Thompson, Cecilia S. Koble, Edward P. Garvey, Scott A. Foster, Jerry Jeffrey, Tamio Fujiwara	5
10	Pyridopyrimidinone inhibitors of HIV-1 RNase H 2014 ·European Journal of Medicinal Chemistry ·(unknown), Brian A. Johns, Peter Gerondelis, Yan Chen, Ming Li, (unknown), Wenwen Zhang, (unknown), Kendra E. Hightower, Sónia Miranda, (unknown), Lisa M. Leesnitzer	16
11	Choosing the right antibody for resistin-like molecule (RELM/FIZZ) family members 2012 ·Histochemistry and Cell Biology ·Chunling Fan, Brian A. Johns, Qingning Su, Irina Kolosova, Roger A. Johns	10
12	Combining symmetry elements results in potent naphthyridinone (NTD) HIV-1 integrase inhibitors 2011 ·Bioorganic & Medicinal Chemistry Letters ·Brian A. Johns, Takashi Kawasuji, Jason G. Weatherhead, Eric E. Boros, James B. Thompson, Edward P. Garvey, Scott A. Foster, Jerry Jeffrey, Wayne H. Miller, Noriyuki Kurose, (unknown), Tamio Fujiwara	6
13	Pyrazolopyrimidines and pyrazolotriazines with potent activity against herpesviruses 2009 ·Bioorganic & Medicinal Chemistry Letters ·Kristjan S. Gudmundsson, Brian A. Johns, Jason G. Weatherhead	52
14	The use of oxadiazole and triazole substituted naphthyridines as HIV-1 integrase inhibitors. Part 1: Establishing the pharmacophore 2009 ·Bioorganic & Medicinal Chemistry Letters ·Brian A. Johns, Jason G. Weatherhead, Scott H. Allen, James B. Thompson, Edward P. Garvey, Scott A. Foster, Jerry Jeffrey, Wayne H. Miller	94
15	Secondary mutations in viruses resistant to HIV-1 integrase inhibitors that restore viral infectivity and replication kinetics 2008 ·Antiviral Research ·Koichiro Nakahara, Chiaki Wakasa-Morimoto, Masanori Kobayashi, Shigeru Miki, Takeshi Noshi, Takahiro Seki, (unknown), (unknown), (unknown), Toshio Fujishita, Tomokazu Yoshinaga, Edward P. Garvey, Brian A. Johns, Scott A. Foster, Mark Underwood, Akihiko Sato, Tamio Fujiwara	46
16	Pyrazolo[1,5-a]pyridine antiherpetics: Effects of the C3 substituent on antiviral activity 2007 ·Bioorganic & Medicinal Chemistry Letters ·Brian A. Johns, Kristjan S. Gudmundsson, Scott H. Allen	28
17	Pyrazolopyridines with potent activity against herpesviruses: Effects of C5 substituents on antiviral activity 2007 ·Bioorganic & Medicinal Chemistry Letters ·Kristjan S. Gudmundsson, Brian A. Johns, Scott H. Allen	51
18	Synthesis and HIV-integrase strand transfer inhibition activity of 7-hydroxy[1,3]thiazolo[5,4-b]pyridin-5(4H)-ones 2006 ·Bioorganic & Medicinal Chemistry Letters ·Eric E. Boros, Brian A. Johns, Edward P. Garvey, Cecilia S. Koble, Wayne H. Miller	37
19	Synthesis of novel substituted 2-phenylpyrazolopyridines with potent activity against herpesviruses 2005 ·Bioorganic & Medicinal Chemistry ·Kristjan S. Gudmundsson, Brian A. Johns, Zhicheng Wang, Elizabeth M. Turner, Scott H. Allen, George A. Freeman, F. Leslie Boyd, Connie J. Sexton, Dean W. Selleseth, (unknown), Katrina L. Creech	48
20	Synthesis of C-6 substituted pyrazolo[1,5-a]pyridines with potent activity against herpesviruses 2005 ·Bioorganic & Medicinal Chemistry ·Scott H. Allen, Brian A. Johns, Kristjan S. Gudmundsson, George A. Freeman, F. Leslie Boyd, (unknown), Dean W. Selleseth, Katrina L. Creech, (unknown)	38

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact